Related Experiment Video
Updated: Aug 9, 2025

06:07
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
5.8K
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience
Kathryn T Maples1, Kevin H Hall2, Nisha S Joseph2
1Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA. Kathryn.maples@emoryhealthcare.org.
Blood Cancer Journal
|February 22, 2023
Abstract
No abstract available in PubMed .

